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TCT-1
Successful Recanalisation of Chronic Total Occlusions is Associated with
Improved Long-Term Survival
Daniel A Jones1, Krishnaraj S Rathod1, Jonathan Behar1, Sean M Gallagher1,
Roshan Weerackody1, Ajay K Jain1, Charles Knight1, Anthony Mathur1, Craig A
Thompson2, Andrew Wragg1, Elliot J Smith1
1Barts and the London NHS Trust, London, United Kingdom; 2Yale University
Department of Cardiology, New Haven, CT
Background: The long-term benefit of chronic total occlusions (CTOs) percutaneous
coronary intervention is still debated. The aim of this study was to investigate the
impact of procedural success on mortality following CTO-PCI in the drug eluting stent
era.
Methods: 6,996 consecutive patients underwent elective PCI at a single centre (2003
-2010), 836 (11.9%) for CTO. In-hospital MACE (myocardial infarction, urgent
revascularisation, stroke or death) was documented at discharge. All cause mortality
data was obtained from the Office of National Statistics out to 5 years (mean 3.6 +/-
1.8) and outcome stratified according to successful or unsuccessful CTO recanalisation.
Results: 582 (69.6%) CTO procedures were successful. Coronary stents were
implanted in 97.0% of successful procedures (mean 2.3 +/-0.1 stents, 73% drug
eluting). Prior revascularisation was more frequent among patients with unsuccessful
CTO-PCI than successful; prior CABG 16.5% vs. 7.4%,; PCI 36.0% vs. 21.2%,
p<0.0001. Baseline characteristics were otherwise similar. Intra-procedural
complications were more frequent in unsuccessful cases (20.5% vs. 4.9% (p=<0.0001),
but did not effect in-hospital MACE (3% vs. 2.1%, p = 0.6). All cause mortality was
17.2% in unsuccessful and 4.5% in successful out to 5 years (Fig 1). Mortality
following successful CTO-PCI was similar to that of the non-CTO elective PCI group
(6.7%, p=0.1). After mutivariate adjustment a successful procedure was predictive of
improved outcome (HR 0.32 (95% CI 0.18-0.58).
K-M curve displaying outcome based on CTO-PCI success
Conclusion: A successful angiographic outcome following CTO-PCI is associated
with a survival advantage out to 5 years following intervention.
TCT-2
Prognostic Impact of Complete Coronary Revascularization in Patients with
Diabetes Mellitus and Chronic Total Occlusions
Renato Valenti, Angela Migliorini, Guido Parodi, Ruben Vergara, Piergiovanni
Buonamici, Giampaolo Cerisano, David Antoniucci
Division of Cardiology, Careggi Hospital, Florence, Italy
Background: Coronary chronic total occlusion (CTO) is frequently associated with
multivessel disease. Large registries have shown a better clinical outcome in patients
with successful CTO-PCI and complete coronary revascularization. No data exist about
the prognostic impact of drug eluting stent (DES) supported successful PCI for CTO
in patients with diabetes mellitus.
Methods: From the prospective Florence CTO-PCI registry, since 2004 to 2010, 902
patients underwent PCI for CTO (>3 months). Out of these, patients with diabetes
mellitus were included in the analysis. The prognostic impact of successful PCI and
of complete coronary revascularization on long-term cardiac survival was assessed by
Kaplan-Meier estimation and by multivariate Cox regression analysis.
Results: Patients with diabetes mellitus were 220 (24%): mean age 68 ± 10 yrs, male
79%, previous myocardial infarction 58%, impaired left ventricular ejection fraction
(EF < 0.40) 47%, 3-vessel coronary disease 55%, left anterior descending artery CTO
30%, right coronary artery CTO 37%. A successful CTO-PCI was achived in 170
patients (77%). All patients with successful PCI received DES in CTO lesions (mean
stent lenght 52 ± 29 mm). A complete coronary revascularization was performed in
64% of patients. The clinical FU rate was 100% (median 1.2 yrs). The cardiac survival
rate was similar in patients with successful CTO-PCI as compared to patients with
unsuccessful CTO-PCI (90% ± 4% vs. 89% ± 5% p=0.279), while it was significant
higher in patients with complete coronary revascularization as compared to incomplete
coronary revascularization group (98% ± 1% vs. 76% ± 7%; p<.001). At multivariate
analysis complete coronary revascularization was an independent predictor related to
cardiac mortality (HR 0.25; p=0.046).
Conclusion: The successful CTO-PCI is the link with a complete coronary
revascularization. In the high risk setting of patients with diabetes mellitus, frequently
associated with multivessel disease and CTO, the main target is to achieve a complete
coronary revascularization in order to improve long-term outcome.
TCT-3
Percutaneous Coronary Intervention for Chronic Total Occlusions : Feasibility,
Safety and Clinical Outcomes at One Year: an Analysis of 307 Patients
Virginie Brandao Carreira, Madjid Hattab, Maher Hakim, Simon Elhadad
Cardiology, Centre Hospitalier Lagny Marne la Vallée, Lagny sur Marne, France
Background: Percutaneous coronary interventions (PCI) for chronic total occlusions
(CTO) are considered difficult, expensive and dangerous procedures. Thus,
enhancement of this technique has been limited. This study aims to review all PCIs
for CTO performed in our department to evaluate its feasibility and safety and to
present clinical outcomes at one year.
Methods: We retrospectively studied all PCIs for CTO defined by TIMI flow grade 0
and duration ≥ 3 months. End points included success rate, in hospital complications,
12-month major adverse cardiac events (MACE) and 12-month symptomatic status.
Results: 307 consecutive patients scheduled for a CTO PCI from 2007 to 2010 were
followed for a period of over one year. Success revascularization was obtained in 84%
of patients while in hospital MACE occurred in 3.5% with a majority of non Q wave
myocardial infarction (MI). Coronary perforation was the main complication observed
(6%) leading to cardiac tamponade in one third. However, none required surgical
repaired. Univariate analysis showed that moderate to severe calcifications and absence
of a tapered stump were the only significant predictors of PCI failure (p<0.0001 and
p=0.005 respectively). At one year, incidence of non fatal MI among patients with
successful procedures was significantly less frequent when compared to failed
procedures (0.4% vs. 6.8%, p=0.001). Also, patients from the first group were
significantly free of angina (98% vs. 39%, p<0.0001) without differences in medical
therapy. In the successful group, 12-month MACE occurred in 13.6% including 12.8%
of target lesion revascularization (TLR). However, ischemic driven TLR was less than
2%.
Conclusion: High success rate is achieved in PCI for CTO when performed by
specialist operators with low in hospital complications rate comparable to the one
observed in non-CTO PCI registries. At one year, patients with successful procedures
experienced a real benefit with symptomatic and clinical outcomes similar to standard
PCI with drug eluting stent implantation.
TCT-4
The Impact of the Location of a Chronic Total Occlusion in a non Infarct
Related Artery on Long-term Mortality in ST-Elevation Myocardial Infarction
Patients
Loes P Hoebers, Bimmer E Claessen, Wouter J Kikkert, Marije M Vis, Karel T Koch,
Jan Baan, Jan G Tijssen, Robbert J de Winter, Jan J Piek, Jose P Henriques
Cardiology, Academic Medical Center, Interventional Cardiology/PCI - Diabetes;
Chronic Total Occlusions, Netherlands
Background: Recently, the impact of a chronic total occlusion (CTO) in a non infarct
related coronary artery (IRA) was shown to be a strong predictor for mortality. We
investigated whether the location of the CTO influenced long term mortality.
Methods: Between 1997-2008, we admitted 533 STEMI patients with a CTO in a non-
IRA. Survival analysis to 5-years follow-up was perforrmed, stratified for the location
of the CTO.
Results: Of the 533 STEMI patients, 228 had a CTO in the RCA, 180 in the RCX and
128 in the LAD. Figure 1 shows the mortality rates at 5 years for patients with a RCA
(39.9%), RCX (31.9%) and LAD (36.5%) which were not significantly different
(p=0.48).
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Conclusion: STEMI patients with a CTO in a non IRA have an increased mortality,
regardless of the coronary location.
TCT-5
Drug-Eluting Stents for the Treatment of Chronic Total Occlusion: A
Comparison with Sirolimus, Paclitaxel, Zotarolimus (Endeavor Resolute),
BiolimusA9, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry
in Asia
Sunao Nakamura1, Hisao Ogawa2, Jang-Ho Bae3, Yeo H Cahyadi4, Wasan
Udayachalerm5, Damras Tresukosol6, Sudaratana Tansuphaswadikul7
1New Tokyo Hospital, Chiba, Japan; 2Kumamoto University Hospital, Kumamoto,
Japan; 3Konyang University Hospital, Daejeon, Republic of Korea; 4Husada
Hospital, Jakarta, Indonesia; 5King Chulalongkorn Memorial Hospital, Bangkok,
Thailand; 6Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok,
Thailand; 7Chest Disease Institute, Nontaburi, Thailand
Background: The aim of this study is to compare the safety and efficacy of Sirolimus
(SES), Paclitaxel (PES), Zotarolimus (ZES-R/ Endeavor Resolute), BiolimusA9 (BES),
EPC capture (ECS) and Everolimus-eluting stent (EES) on the outcome of patients
with chronic total occlusion (CTO).
Methods: A prospective analysis of 1576 patients with 1738 CTOs (396 SES, 526
PES, 219 ZES-R, 209 BES, 148 ECS, 240 EES) in six high volume Asian centers after
successful recanalization of CTO was performed. The study endpoints were 30 days
and 12 months major adverse cardiac events (MACE), 12 months angiographic
restenosis and target lesion revascularization (TLR).
Results: See table for clinical results.
Conclusion: The use of drug-eluting stents in patients with CTO was safe with low
acute complication. Patients treated with 2nd generation DES such as ZES-R, BES
and EES showed lesser rate of restenosis compared with 1st generation drug-eluting
stents.
TCT-6
Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for
Chronic Total Occlusions in Insulin and Non-Insulin Dependent Diabetes
Mellitus: Five-Year Outcomes from a 1,791 Patient Multi-National Registry
Bimmer E Claessen1, 2, Cosmo Godino3, Kotaro Obunai1, Sunil Kanwal1, Mauro
Carlino3, Young-Hak Kim4, Carlo DiMario5, José P Henriques2, Seung-Jung Park4,
Gregg W Stone1, Martin B Leon1, George D Dangas1, Antonio Colombo3, Roxana
Mehran1
1Cardiology, Cardiovascular Research Foundation, New York, NY; 2Academic
Medical Center - University of Amsterdam, Amsterdam, Netherlands; 3San Raffaele
Scientific Institute, Milan, Italy; 4Asan Medical Center, Seoul, Republic of Korea;
5Royal Brompton Hospital, London, United Kingdom
Background: There is a paucity of data on long-term clinical outcomes of patients
with insulin dependent diabetes mellitus (IDDM) compared with non-IDDM
undergoing percutaneous coronary intervention (PCI) for chronic total occlusions
(CTO).
Methods: Between 1998 and 2007, a total of 1791 pts with 1852 CTO underwent PCI
at three centers in the US, Italy and South Korea. Time-to-event analyses were
performed using Kaplan-Meier statistics and the log-rank statistic was used to test for
differences between pts with and without DM. Cox regression was used for multivariate
analysis.
Results: A total of 395 (23%) patients had DM, 164 had IDDM (42%) and 231 had
non-IDDM (58%). Procedural success was similar in pts with IDDM and non-IDDM
(68% vs. 71%, p=0.48). After a successful procedure, stents were implanted in 106
patients with IDDM (87% DES) and 159 patients with Non-IDDM (69% DES).Median
follow-up duration was 1080 days. Five-year mortality was significantly increased in
patients with IDDM (23% vs. 7%, p=0.02, figure 1a). After multivariate adjustment,
IDDM remained an independent predictor of mortality (HR 2.25, 95% CI 1.04-4.87,
p=0.04). Other independent predictors were age (HR 1.1, p<0.01) and procedural
success (HR 0.44, p=0.03). Five-year TVR rates after successful PCI were similar in
patients with IDDM and Non-IDDM (24% vs. 27%, p=0.56, figure 1b).
Conclusion: In diabetic patients undergoing CTO PCI, IDDM was an independent
predictor of 5-year mortality. After a successful procedure, TVR rates were similar in
patients with IDDM and non-IDDM.
TCT-7
MSCT Guided Co-registration for CTO Procedures - A Pilot Feasibility Study
Ravit Barkama, Giora Weisz, Fernando Sosa, Angelica Castaneda, Diane Weber-
Cannone, Lauren Privitera, Sunil Kanwal, Ahmed Hassanin, Varinder Singh,
Michael Collins, Martin B Leon, Jeffrey W Moses
Columbia University Medical Center, New York, NY
Background: Since traditional coronary angiography provides images of the coronary
vessel lumen, chronic total occlusions (CTO) segments are not visible using this
modality. Multislice Computed Tomography (MSCT) provides information on the soft
tissue surrounding the vessel lumen, so it can be used to identify morphological features
such as actual length of the occluded segment, tortuosity and the amount of
calcification. The 3D nature of MSCT allows accurate measurements of length that do
not suffer from calibration limitations and foreshortening. The purpose of this study
was to evaluate the feasibility and operator-perceived added value of advanced software
that provides real time fusion of MSCT images onto the live fluoroscopy during CTO
recanalization.
Methods: In this feasibility study, a software prototype (GE Healthcare, Waukesha,
US) allowing MSCT image fusion with fluoroscopy was used. Manual registration was
performed using anatomical landmarks, such as the vessel ostia and calcifications. This
initial phase of image fusion enabled the operator to plan the procedure. Visualized
portions of the occluded vessel were displayed over the fluoroscopy image in real time,
using ECG gating to match the cardiac phase of the two modalities. The 3D soft tissue
reconstruction of the occluded lumen was displayed on a separate screen allowing real-
time comparison, side by side, between fluoroscopy and MSCT co-registration.
Results: MSCT guided co-registration was performed for a total of 21 CTO
procedures. Real-time registration was successful in all cases and aided in selection of
the view that would provide the least foreshortening and minimal vessel overlapping.
Successful CTO recanalization was achieved in 16 (76%) of the cases. Post-procedural
assessment by the operators ranked the device usefulness as “Very High” in 5 of the
cases, “High” in 9, “Moderate” in 4 and of “Little or No Value” in 3.
Conclusion: This pilot feasibility study demonstrated that MSCT co-registration is
feasible, easily integrated into the standard procedure and is perceived in the majority
of cases as a highly useful tool for CTO recanalization. Further research is warranted
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